Global Drugs based on Genetic Engineering Market Research Report 2026(Status and Outlook)
Drugs based on genetic engineering are pharmaceutical products developed using biotechnology techniques such as recombinant DNA technology, gene editing, or synthetic biology. These drugs are typically proteins, peptides, nucleic acids, or living cells that are designed to prevent, treat, or cure diseases by modifying or influencing genetic or molecular pathways in the body.
The global Drugs based on Genetic Engineering market size was estimated at USD 314526.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drugs based on Genetic Engineering market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drugs based on Genetic Engineering market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drugs based on Genetic Engineering market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drugs based on Genetic Engineering Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drugs based on Genetic Engineering, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Drugs based on Genetic Engineering market size was estimated at USD 314526.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.80% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Drugs based on Genetic Engineering market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Drugs based on Genetic Engineering market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Drugs based on Genetic Engineering market.
Global Drugs based on Genetic Engineering Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Novo Nordisk
- Amgen
- Eli Lilly
- Sanofi
- Bayer
- Bristol-Myers Squibb
- GlaxoSmithKline
- AbbVie
- Sandoz
- Biogen
- Pfizer
- GenSci
- 3SBIO
- Organon Pharma
- Roche
- Swedish Orphan Biovitrum
- CSPC
- Johnson & Johnson
- Merck
- Takeda
Market Segmentation (by Type)
- Fusion Protein
- Recombinant Growth Factor
- Recombinant Hormone
- Recombinant Interferon
- Recombinant Interleukin
- Recombinant Coagulation Factor
- Other
Market Segmentation (by Application)
- Cancers
- Autoimmune Diseases
- Metabolic Disorders
- Infectious Diseases
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Drugs based on Genetic Engineering Market
Overview of the regional outlook of the Drugs based on Genetic Engineering Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Drugs based on Genetic Engineering Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Drugs based on Genetic Engineering, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Drugs based on Genetic Engineering
1.2 Key Market Segments
1.2.1 Drugs based on Genetic Engineering Segment by Type
1.2.2 Drugs based on Genetic Engineering Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUGS BASED ON GENETIC ENGINEERING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drugs based on Genetic Engineering Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drugs based on Genetic Engineering Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUGS BASED ON GENETIC ENGINEERING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drugs based on Genetic Engineering Product Life Cycle
3.3 Global Drugs based on Genetic Engineering Sales by Manufacturers (2020-2025)
3.4 Global Drugs based on Genetic Engineering Revenue Market Share by Manufacturers (2020-2025)
3.5 Drugs based on Genetic Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drugs based on Genetic Engineering Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Drugs based on Genetic Engineering Market Competitive Situation and Trends
3.8.1 Drugs based on Genetic Engineering Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drugs based on Genetic Engineering Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUGS BASED ON GENETIC ENGINEERING INDUSTRY CHAIN ANALYSIS
4.1 Drugs based on Genetic Engineering Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUGS BASED ON GENETIC ENGINEERING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drugs based on Genetic Engineering Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drugs based on Genetic Engineering Market
5.7 ESG Ratings of Leading Companies
6 DRUGS BASED ON GENETIC ENGINEERING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drugs based on Genetic Engineering Sales Market Share by Type (2020-2025)
6.3 Global Drugs based on Genetic Engineering Market Size by Type (2020-2025)
6.4 Global Drugs based on Genetic Engineering Price by Type (2020-2025)
7 DRUGS BASED ON GENETIC ENGINEERING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drugs based on Genetic Engineering Market Sales by Application (2020-2025)
7.3 Global Drugs based on Genetic Engineering Market Size (M USD) by Application (2020-2025)
7.4 Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
8 DRUGS BASED ON GENETIC ENGINEERING MARKET SALES BY REGION
8.1 Global Drugs based on Genetic Engineering Sales by Region
8.1.1 Global Drugs based on Genetic Engineering Sales by Region
8.1.2 Global Drugs based on Genetic Engineering Sales Market Share by Region
8.2 Global Drugs based on Genetic Engineering Market Size by Region
8.2.1 Global Drugs based on Genetic Engineering Market Size by Region
8.2.2 Global Drugs based on Genetic Engineering Market Size by Region
8.3 North America
8.3.1 North America Drugs based on Genetic Engineering Sales by Country
8.3.2 North America Drugs based on Genetic Engineering Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drugs based on Genetic Engineering Sales by Country
8.4.2 Europe Drugs based on Genetic Engineering Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drugs based on Genetic Engineering Sales by Region
8.5.2 Asia Pacific Drugs based on Genetic Engineering Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drugs based on Genetic Engineering Sales by Country
8.6.2 South America Drugs based on Genetic Engineering Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drugs based on Genetic Engineering Sales by Region
8.7.2 Middle East and Africa Drugs based on Genetic Engineering Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUGS BASED ON GENETIC ENGINEERING MARKET PRODUCTION BY REGION
9.1 Global Production of Drugs based on Genetic Engineering by Region(2020-2025)
9.2 Global Drugs based on Genetic Engineering Revenue Market Share by Region (2020-2025)
9.3 Global Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drugs based on Genetic Engineering Production
9.4.1 North America Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.4.2 North America Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drugs based on Genetic Engineering Production
9.5.1 Europe Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.5.2 Europe Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drugs based on Genetic Engineering Production (2020-2025)
9.6.1 Japan Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.6.2 Japan Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drugs based on Genetic Engineering Production (2020-2025)
9.7.1 China Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.7.2 China Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk Drugs based on Genetic Engineering Product Overview
10.1.3 Novo Nordisk Drugs based on Genetic Engineering Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Drugs based on Genetic Engineering Product Overview
10.2.3 Amgen Drugs based on Genetic Engineering Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Eli Lilly
10.3.1 Eli Lilly Basic Information
10.3.2 Eli Lilly Drugs based on Genetic Engineering Product Overview
10.3.3 Eli Lilly Drugs based on Genetic Engineering Product Market Performance
10.3.4 Eli Lilly Business Overview
10.3.5 Eli Lilly SWOT Analysis
10.3.6 Eli Lilly Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Drugs based on Genetic Engineering Product Overview
10.4.3 Sanofi Drugs based on Genetic Engineering Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Bayer
10.5.1 Bayer Basic Information
10.5.2 Bayer Drugs based on Genetic Engineering Product Overview
10.5.3 Bayer Drugs based on Genetic Engineering Product Market Performance
10.5.4 Bayer Business Overview
10.5.5 Bayer Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Basic Information
10.6.2 Bristol-Myers Squibb Drugs based on Genetic Engineering Product Overview
10.6.3 Bristol-Myers Squibb Drugs based on Genetic Engineering Product Market Performance
10.6.4 Bristol-Myers Squibb Business Overview
10.6.5 Bristol-Myers Squibb Recent Developments
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Basic Information
10.7.2 GlaxoSmithKline Drugs based on Genetic Engineering Product Overview
10.7.3 GlaxoSmithKline Drugs based on Genetic Engineering Product Market Performance
10.7.4 GlaxoSmithKline Business Overview
10.7.5 GlaxoSmithKline Recent Developments
10.8 AbbVie
10.8.1 AbbVie Basic Information
10.8.2 AbbVie Drugs based on Genetic Engineering Product Overview
10.8.3 AbbVie Drugs based on Genetic Engineering Product Market Performance
10.8.4 AbbVie Business Overview
10.8.5 AbbVie Recent Developments
10.9 Sandoz
10.9.1 Sandoz Basic Information
10.9.2 Sandoz Drugs based on Genetic Engineering Product Overview
10.9.3 Sandoz Drugs based on Genetic Engineering Product Market Performance
10.9.4 Sandoz Business Overview
10.9.5 Sandoz Recent Developments
10.10 Biogen
10.10.1 Biogen Basic Information
10.10.2 Biogen Drugs based on Genetic Engineering Product Overview
10.10.3 Biogen Drugs based on Genetic Engineering Product Market Performance
10.10.4 Biogen Business Overview
10.10.5 Biogen Recent Developments
10.11 Pfizer
10.11.1 Pfizer Basic Information
10.11.2 Pfizer Drugs based on Genetic Engineering Product Overview
10.11.3 Pfizer Drugs based on Genetic Engineering Product Market Performance
10.11.4 Pfizer Business Overview
10.11.5 Pfizer Recent Developments
10.12 GenSci
10.12.1 GenSci Basic Information
10.12.2 GenSci Drugs based on Genetic Engineering Product Overview
10.12.3 GenSci Drugs based on Genetic Engineering Product Market Performance
10.12.4 GenSci Business Overview
10.12.5 GenSci Recent Developments
10.13 3SBIO
10.13.1 3SBIO Basic Information
10.13.2 3SBIO Drugs based on Genetic Engineering Product Overview
10.13.3 3SBIO Drugs based on Genetic Engineering Product Market Performance
10.13.4 3SBIO Business Overview
10.13.5 3SBIO Recent Developments
10.14 Organon Pharma
10.14.1 Organon Pharma Basic Information
10.14.2 Organon Pharma Drugs based on Genetic Engineering Product Overview
10.14.3 Organon Pharma Drugs based on Genetic Engineering Product Market Performance
10.14.4 Organon Pharma Business Overview
10.14.5 Organon Pharma Recent Developments
10.15 Roche
10.15.1 Roche Basic Information
10.15.2 Roche Drugs based on Genetic Engineering Product Overview
10.15.3 Roche Drugs based on Genetic Engineering Product Market Performance
10.15.4 Roche Business Overview
10.15.5 Roche Recent Developments
10.16 Swedish Orphan Biovitrum
10.16.1 Swedish Orphan Biovitrum Basic Information
10.16.2 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Overview
10.16.3 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Market Performance
10.16.4 Swedish Orphan Biovitrum Business Overview
10.16.5 Swedish Orphan Biovitrum Recent Developments
10.17 CSPC
10.17.1 CSPC Basic Information
10.17.2 CSPC Drugs based on Genetic Engineering Product Overview
10.17.3 CSPC Drugs based on Genetic Engineering Product Market Performance
10.17.4 CSPC Business Overview
10.17.5 CSPC Recent Developments
10.18 Johnson and Johnson
10.18.1 Johnson and Johnson Basic Information
10.18.2 Johnson and Johnson Drugs based on Genetic Engineering Product Overview
10.18.3 Johnson and Johnson Drugs based on Genetic Engineering Product Market Performance
10.18.4 Johnson and Johnson Business Overview
10.18.5 Johnson and Johnson Recent Developments
10.19 Merck
10.19.1 Merck Basic Information
10.19.2 Merck Drugs based on Genetic Engineering Product Overview
10.19.3 Merck Drugs based on Genetic Engineering Product Market Performance
10.19.4 Merck Business Overview
10.19.5 Merck Recent Developments
10.20 Takeda
10.20.1 Takeda Basic Information
10.20.2 Takeda Drugs based on Genetic Engineering Product Overview
10.20.3 Takeda Drugs based on Genetic Engineering Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 DRUGS BASED ON GENETIC ENGINEERING MARKET FORECAST BY REGION
11.1 Global Drugs based on Genetic Engineering Market Size Forecast
11.2 Global Drugs based on Genetic Engineering Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drugs based on Genetic Engineering Market Size Forecast by Country
11.2.3 Asia Pacific Drugs based on Genetic Engineering Market Size Forecast by Region
11.2.4 South America Drugs based on Genetic Engineering Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drugs based on Genetic Engineering by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drugs based on Genetic Engineering Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drugs based on Genetic Engineering by Type (2026-2035)
12.1.2 Global Drugs based on Genetic Engineering Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drugs based on Genetic Engineering by Type (2026-2035)
12.2 Global Drugs based on Genetic Engineering Market Forecast by Application (2026-2035)
12.2.1 Global Drugs based on Genetic Engineering Sales (K MT) Forecast by Application
12.2.2 Global Drugs based on Genetic Engineering Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Drugs based on Genetic Engineering
1.2 Key Market Segments
1.2.1 Drugs based on Genetic Engineering Segment by Type
1.2.2 Drugs based on Genetic Engineering Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 DRUGS BASED ON GENETIC ENGINEERING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Drugs based on Genetic Engineering Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Drugs based on Genetic Engineering Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 DRUGS BASED ON GENETIC ENGINEERING MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Drugs based on Genetic Engineering Product Life Cycle
3.3 Global Drugs based on Genetic Engineering Sales by Manufacturers (2020-2025)
3.4 Global Drugs based on Genetic Engineering Revenue Market Share by Manufacturers (2020-2025)
3.5 Drugs based on Genetic Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Drugs based on Genetic Engineering Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Drugs based on Genetic Engineering Market Competitive Situation and Trends
3.8.1 Drugs based on Genetic Engineering Market Concentration Rate
3.8.2 Global 5 and 10 Largest Drugs based on Genetic Engineering Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 DRUGS BASED ON GENETIC ENGINEERING INDUSTRY CHAIN ANALYSIS
4.1 Drugs based on Genetic Engineering Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF DRUGS BASED ON GENETIC ENGINEERING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Drugs based on Genetic Engineering Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Drugs based on Genetic Engineering Market
5.7 ESG Ratings of Leading Companies
6 DRUGS BASED ON GENETIC ENGINEERING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Drugs based on Genetic Engineering Sales Market Share by Type (2020-2025)
6.3 Global Drugs based on Genetic Engineering Market Size by Type (2020-2025)
6.4 Global Drugs based on Genetic Engineering Price by Type (2020-2025)
7 DRUGS BASED ON GENETIC ENGINEERING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Drugs based on Genetic Engineering Market Sales by Application (2020-2025)
7.3 Global Drugs based on Genetic Engineering Market Size (M USD) by Application (2020-2025)
7.4 Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
8 DRUGS BASED ON GENETIC ENGINEERING MARKET SALES BY REGION
8.1 Global Drugs based on Genetic Engineering Sales by Region
8.1.1 Global Drugs based on Genetic Engineering Sales by Region
8.1.2 Global Drugs based on Genetic Engineering Sales Market Share by Region
8.2 Global Drugs based on Genetic Engineering Market Size by Region
8.2.1 Global Drugs based on Genetic Engineering Market Size by Region
8.2.2 Global Drugs based on Genetic Engineering Market Size by Region
8.3 North America
8.3.1 North America Drugs based on Genetic Engineering Sales by Country
8.3.2 North America Drugs based on Genetic Engineering Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Drugs based on Genetic Engineering Sales by Country
8.4.2 Europe Drugs based on Genetic Engineering Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Drugs based on Genetic Engineering Sales by Region
8.5.2 Asia Pacific Drugs based on Genetic Engineering Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Drugs based on Genetic Engineering Sales by Country
8.6.2 South America Drugs based on Genetic Engineering Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Drugs based on Genetic Engineering Sales by Region
8.7.2 Middle East and Africa Drugs based on Genetic Engineering Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 DRUGS BASED ON GENETIC ENGINEERING MARKET PRODUCTION BY REGION
9.1 Global Production of Drugs based on Genetic Engineering by Region(2020-2025)
9.2 Global Drugs based on Genetic Engineering Revenue Market Share by Region (2020-2025)
9.3 Global Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Drugs based on Genetic Engineering Production
9.4.1 North America Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.4.2 North America Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Drugs based on Genetic Engineering Production
9.5.1 Europe Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.5.2 Europe Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Drugs based on Genetic Engineering Production (2020-2025)
9.6.1 Japan Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.6.2 Japan Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Drugs based on Genetic Engineering Production (2020-2025)
9.7.1 China Drugs based on Genetic Engineering Production Growth Rate (2020-2025)
9.7.2 China Drugs based on Genetic Engineering Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Novo Nordisk
10.1.1 Novo Nordisk Basic Information
10.1.2 Novo Nordisk Drugs based on Genetic Engineering Product Overview
10.1.3 Novo Nordisk Drugs based on Genetic Engineering Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Amgen
10.2.1 Amgen Basic Information
10.2.2 Amgen Drugs based on Genetic Engineering Product Overview
10.2.3 Amgen Drugs based on Genetic Engineering Product Market Performance
10.2.4 Amgen Business Overview
10.2.5 Amgen SWOT Analysis
10.2.6 Amgen Recent Developments
10.3 Eli Lilly
10.3.1 Eli Lilly Basic Information
10.3.2 Eli Lilly Drugs based on Genetic Engineering Product Overview
10.3.3 Eli Lilly Drugs based on Genetic Engineering Product Market Performance
10.3.4 Eli Lilly Business Overview
10.3.5 Eli Lilly SWOT Analysis
10.3.6 Eli Lilly Recent Developments
10.4 Sanofi
10.4.1 Sanofi Basic Information
10.4.2 Sanofi Drugs based on Genetic Engineering Product Overview
10.4.3 Sanofi Drugs based on Genetic Engineering Product Market Performance
10.4.4 Sanofi Business Overview
10.4.5 Sanofi Recent Developments
10.5 Bayer
10.5.1 Bayer Basic Information
10.5.2 Bayer Drugs based on Genetic Engineering Product Overview
10.5.3 Bayer Drugs based on Genetic Engineering Product Market Performance
10.5.4 Bayer Business Overview
10.5.5 Bayer Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Basic Information
10.6.2 Bristol-Myers Squibb Drugs based on Genetic Engineering Product Overview
10.6.3 Bristol-Myers Squibb Drugs based on Genetic Engineering Product Market Performance
10.6.4 Bristol-Myers Squibb Business Overview
10.6.5 Bristol-Myers Squibb Recent Developments
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Basic Information
10.7.2 GlaxoSmithKline Drugs based on Genetic Engineering Product Overview
10.7.3 GlaxoSmithKline Drugs based on Genetic Engineering Product Market Performance
10.7.4 GlaxoSmithKline Business Overview
10.7.5 GlaxoSmithKline Recent Developments
10.8 AbbVie
10.8.1 AbbVie Basic Information
10.8.2 AbbVie Drugs based on Genetic Engineering Product Overview
10.8.3 AbbVie Drugs based on Genetic Engineering Product Market Performance
10.8.4 AbbVie Business Overview
10.8.5 AbbVie Recent Developments
10.9 Sandoz
10.9.1 Sandoz Basic Information
10.9.2 Sandoz Drugs based on Genetic Engineering Product Overview
10.9.3 Sandoz Drugs based on Genetic Engineering Product Market Performance
10.9.4 Sandoz Business Overview
10.9.5 Sandoz Recent Developments
10.10 Biogen
10.10.1 Biogen Basic Information
10.10.2 Biogen Drugs based on Genetic Engineering Product Overview
10.10.3 Biogen Drugs based on Genetic Engineering Product Market Performance
10.10.4 Biogen Business Overview
10.10.5 Biogen Recent Developments
10.11 Pfizer
10.11.1 Pfizer Basic Information
10.11.2 Pfizer Drugs based on Genetic Engineering Product Overview
10.11.3 Pfizer Drugs based on Genetic Engineering Product Market Performance
10.11.4 Pfizer Business Overview
10.11.5 Pfizer Recent Developments
10.12 GenSci
10.12.1 GenSci Basic Information
10.12.2 GenSci Drugs based on Genetic Engineering Product Overview
10.12.3 GenSci Drugs based on Genetic Engineering Product Market Performance
10.12.4 GenSci Business Overview
10.12.5 GenSci Recent Developments
10.13 3SBIO
10.13.1 3SBIO Basic Information
10.13.2 3SBIO Drugs based on Genetic Engineering Product Overview
10.13.3 3SBIO Drugs based on Genetic Engineering Product Market Performance
10.13.4 3SBIO Business Overview
10.13.5 3SBIO Recent Developments
10.14 Organon Pharma
10.14.1 Organon Pharma Basic Information
10.14.2 Organon Pharma Drugs based on Genetic Engineering Product Overview
10.14.3 Organon Pharma Drugs based on Genetic Engineering Product Market Performance
10.14.4 Organon Pharma Business Overview
10.14.5 Organon Pharma Recent Developments
10.15 Roche
10.15.1 Roche Basic Information
10.15.2 Roche Drugs based on Genetic Engineering Product Overview
10.15.3 Roche Drugs based on Genetic Engineering Product Market Performance
10.15.4 Roche Business Overview
10.15.5 Roche Recent Developments
10.16 Swedish Orphan Biovitrum
10.16.1 Swedish Orphan Biovitrum Basic Information
10.16.2 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Overview
10.16.3 Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Market Performance
10.16.4 Swedish Orphan Biovitrum Business Overview
10.16.5 Swedish Orphan Biovitrum Recent Developments
10.17 CSPC
10.17.1 CSPC Basic Information
10.17.2 CSPC Drugs based on Genetic Engineering Product Overview
10.17.3 CSPC Drugs based on Genetic Engineering Product Market Performance
10.17.4 CSPC Business Overview
10.17.5 CSPC Recent Developments
10.18 Johnson and Johnson
10.18.1 Johnson and Johnson Basic Information
10.18.2 Johnson and Johnson Drugs based on Genetic Engineering Product Overview
10.18.3 Johnson and Johnson Drugs based on Genetic Engineering Product Market Performance
10.18.4 Johnson and Johnson Business Overview
10.18.5 Johnson and Johnson Recent Developments
10.19 Merck
10.19.1 Merck Basic Information
10.19.2 Merck Drugs based on Genetic Engineering Product Overview
10.19.3 Merck Drugs based on Genetic Engineering Product Market Performance
10.19.4 Merck Business Overview
10.19.5 Merck Recent Developments
10.20 Takeda
10.20.1 Takeda Basic Information
10.20.2 Takeda Drugs based on Genetic Engineering Product Overview
10.20.3 Takeda Drugs based on Genetic Engineering Product Market Performance
10.20.4 Takeda Business Overview
10.20.5 Takeda Recent Developments
11 DRUGS BASED ON GENETIC ENGINEERING MARKET FORECAST BY REGION
11.1 Global Drugs based on Genetic Engineering Market Size Forecast
11.2 Global Drugs based on Genetic Engineering Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Drugs based on Genetic Engineering Market Size Forecast by Country
11.2.3 Asia Pacific Drugs based on Genetic Engineering Market Size Forecast by Region
11.2.4 South America Drugs based on Genetic Engineering Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Drugs based on Genetic Engineering by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Drugs based on Genetic Engineering Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Drugs based on Genetic Engineering by Type (2026-2035)
12.1.2 Global Drugs based on Genetic Engineering Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Drugs based on Genetic Engineering by Type (2026-2035)
12.2 Global Drugs based on Genetic Engineering Market Forecast by Application (2026-2035)
12.2.1 Global Drugs based on Genetic Engineering Sales (K MT) Forecast by Application
12.2.2 Global Drugs based on Genetic Engineering Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drugs based on Genetic Engineering Market Size by Type (M USD)
Table 4. Global Drugs based on Genetic Engineering Market Size by Application
Table 5. Drugs based on Genetic Engineering Market Size Comparison by Region (M USD)
Table 6. Global Drugs based on Genetic Engineering Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drugs based on Genetic Engineering Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drugs based on Genetic Engineering Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drugs based on Genetic Engineering Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs based on Genetic Engineering as of 2025)
Table 11. Global Market Drugs based on Genetic Engineering Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Drugs based on Genetic Engineering Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drugs based on Genetic Engineering Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drugs based on Genetic Engineering Sales by Type (K MT)
Table 27. Global Drugs based on Genetic Engineering Market Size by Type (M USD)
Table 28. Global Drugs based on Genetic Engineering Sales (K MT) by Type (2020-2025)
Table 29. Global Drugs based on Genetic Engineering Sales Market Share by Type (2020-2025)
Table 30. Global Drugs based on Genetic Engineering Market Size (M USD) by Type (2020-2025)
Table 31. Global Drugs based on Genetic Engineering Market Share by Type (2020-2025)
Table 32. Global Drugs based on Genetic Engineering Price (USD/KG) by Type (2020-2025)
Table 33. Global Drugs based on Genetic Engineering Sales (K MT) by Application
Table 34. Global Drugs based on Genetic Engineering Market Size by Application
Table 35. Global Drugs based on Genetic Engineering Sales by Application (2020-2025) & (K MT)
Table 36. Global Drugs based on Genetic Engineering Sales Market Share by Application (2020-2025)
Table 37. Global Drugs based on Genetic Engineering Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drugs based on Genetic Engineering Market Share by Application (2020-2025)
Table 39. Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
Table 40. Global Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 41. Global Drugs based on Genetic Engineering Sales Market Share by Region (2020-2025)
Table 42. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025)
Table 44. North America Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 45. North America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 47. Europe Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 51. South America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drugs based on Genetic Engineering Production (K MT) by Region(2020-2025)
Table 55. Global Drugs based on Genetic Engineering Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drugs based on Genetic Engineering Revenue Market Share by Region (2020-2025)
Table 57. Global Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk Drugs based on Genetic Engineering Product Overview
Table 64. Novo Nordisk Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Drugs based on Genetic Engineering Product Overview
Table 70. Amgen Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. Eli Lilly Basic Information
Table 75. Eli Lilly Drugs based on Genetic Engineering Product Overview
Table 76. Eli Lilly Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly SWOT Analysis
Table 79. Eli Lilly Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Drugs based on Genetic Engineering Product Overview
Table 82. Sanofi Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Bayer Basic Information
Table 86. Bayer Drugs based on Genetic Engineering Product Overview
Table 87. Bayer Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bayer Business Overview
Table 89. Bayer Recent Developments
Table 90. Bristol-Myers Squibb Basic Information
Table 91. Bristol-Myers Squibb Drugs based on Genetic Engineering Product Overview
Table 92. Bristol-Myers Squibb Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Recent Developments
Table 95. GlaxoSmithKline Basic Information
Table 96. GlaxoSmithKline Drugs based on Genetic Engineering Product Overview
Table 97. GlaxoSmithKline Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Recent Developments
Table 100. AbbVie Basic Information
Table 101. AbbVie Drugs based on Genetic Engineering Product Overview
Table 102. AbbVie Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AbbVie Business Overview
Table 104. AbbVie Recent Developments
Table 105. Sandoz Basic Information
Table 106. Sandoz Drugs based on Genetic Engineering Product Overview
Table 107. Sandoz Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sandoz Business Overview
Table 109. Sandoz Recent Developments
Table 110. Biogen Basic Information
Table 111. Biogen Drugs based on Genetic Engineering Product Overview
Table 112. Biogen Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Biogen Business Overview
Table 114. Biogen Recent Developments
Table 115. Pfizer Basic Information
Table 116. Pfizer Drugs based on Genetic Engineering Product Overview
Table 117. Pfizer Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Pfizer Business Overview
Table 119. Pfizer Recent Developments
Table 120. GenSci Basic Information
Table 121. GenSci Drugs based on Genetic Engineering Product Overview
Table 122. GenSci Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. GenSci Business Overview
Table 124. GenSci Recent Developments
Table 125. 3SBIO Basic Information
Table 126. 3SBIO Drugs based on Genetic Engineering Product Overview
Table 127. 3SBIO Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. 3SBIO Business Overview
Table 129. 3SBIO Recent Developments
Table 130. Organon Pharma Basic Information
Table 131. Organon Pharma Drugs based on Genetic Engineering Product Overview
Table 132. Organon Pharma Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Organon Pharma Business Overview
Table 134. Organon Pharma Recent Developments
Table 135. Roche Basic Information
Table 136. Roche Drugs based on Genetic Engineering Product Overview
Table 137. Roche Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Roche Business Overview
Table 139. Roche Recent Developments
Table 140. Swedish Orphan Biovitrum Basic Information
Table 141. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Overview
Table 142. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Swedish Orphan Biovitrum Business Overview
Table 144. Swedish Orphan Biovitrum Recent Developments
Table 145. CSPC Basic Information
Table 146. CSPC Drugs based on Genetic Engineering Product Overview
Table 147. CSPC Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. CSPC Business Overview
Table 149. CSPC Recent Developments
Table 150. Johnson and Johnson Basic Information
Table 151. Johnson and Johnson Drugs based on Genetic Engineering Product Overview
Table 152. Johnson and Johnson Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Johnson and Johnson Business Overview
Table 154. Johnson and Johnson Recent Developments
Table 155. Merck Basic Information
Table 156. Merck Drugs based on Genetic Engineering Product Overview
Table 157. Merck Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Merck Business Overview
Table 159. Merck Recent Developments
Table 160. Takeda Basic Information
Table 161. Takeda Drugs based on Genetic Engineering Product Overview
Table 162. Takeda Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Takeda Business Overview
Table 164. Takeda Recent Developments
Table 165. Global Drugs based on Genetic Engineering Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Drugs based on Genetic Engineering Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Drugs based on Genetic Engineering Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Drugs based on Genetic Engineering Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Drugs based on Genetic Engineering Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Drugs based on Genetic Engineering Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Drugs based on Genetic Engineering Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Drugs based on Genetic Engineering Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Drugs based on Genetic Engineering Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Drugs based on Genetic Engineering Market Size by Type (M USD)
Table 4. Global Drugs based on Genetic Engineering Market Size by Application
Table 5. Drugs based on Genetic Engineering Market Size Comparison by Region (M USD)
Table 6. Global Drugs based on Genetic Engineering Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Drugs based on Genetic Engineering Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Drugs based on Genetic Engineering Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Drugs based on Genetic Engineering Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs based on Genetic Engineering as of 2025)
Table 11. Global Market Drugs based on Genetic Engineering Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Drugs based on Genetic Engineering Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Drugs based on Genetic Engineering Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Drugs based on Genetic Engineering Sales by Type (K MT)
Table 27. Global Drugs based on Genetic Engineering Market Size by Type (M USD)
Table 28. Global Drugs based on Genetic Engineering Sales (K MT) by Type (2020-2025)
Table 29. Global Drugs based on Genetic Engineering Sales Market Share by Type (2020-2025)
Table 30. Global Drugs based on Genetic Engineering Market Size (M USD) by Type (2020-2025)
Table 31. Global Drugs based on Genetic Engineering Market Share by Type (2020-2025)
Table 32. Global Drugs based on Genetic Engineering Price (USD/KG) by Type (2020-2025)
Table 33. Global Drugs based on Genetic Engineering Sales (K MT) by Application
Table 34. Global Drugs based on Genetic Engineering Market Size by Application
Table 35. Global Drugs based on Genetic Engineering Sales by Application (2020-2025) & (K MT)
Table 36. Global Drugs based on Genetic Engineering Sales Market Share by Application (2020-2025)
Table 37. Global Drugs based on Genetic Engineering Market Size by Application (2020-2025) & (M USD)
Table 38. Global Drugs based on Genetic Engineering Market Share by Application (2020-2025)
Table 39. Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
Table 40. Global Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 41. Global Drugs based on Genetic Engineering Sales Market Share by Region (2020-2025)
Table 42. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 43. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025)
Table 44. North America Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 45. North America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 47. Europe Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 50. South America Drugs based on Genetic Engineering Sales by Country (2020-2025) & (K MT)
Table 51. South America Drugs based on Genetic Engineering Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Drugs based on Genetic Engineering Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Drugs based on Genetic Engineering Market Size by Region (2020-2025) & (M USD)
Table 54. Global Drugs based on Genetic Engineering Production (K MT) by Region(2020-2025)
Table 55. Global Drugs based on Genetic Engineering Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Drugs based on Genetic Engineering Revenue Market Share by Region (2020-2025)
Table 57. Global Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Drugs based on Genetic Engineering Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Novo Nordisk Basic Information
Table 63. Novo Nordisk Drugs based on Genetic Engineering Product Overview
Table 64. Novo Nordisk Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk SWOT Analysis
Table 67. Novo Nordisk Recent Developments
Table 68. Amgen Basic Information
Table 69. Amgen Drugs based on Genetic Engineering Product Overview
Table 70. Amgen Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Amgen Business Overview
Table 72. Amgen SWOT Analysis
Table 73. Amgen Recent Developments
Table 74. Eli Lilly Basic Information
Table 75. Eli Lilly Drugs based on Genetic Engineering Product Overview
Table 76. Eli Lilly Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly SWOT Analysis
Table 79. Eli Lilly Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Drugs based on Genetic Engineering Product Overview
Table 82. Sanofi Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. Bayer Basic Information
Table 86. Bayer Drugs based on Genetic Engineering Product Overview
Table 87. Bayer Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Bayer Business Overview
Table 89. Bayer Recent Developments
Table 90. Bristol-Myers Squibb Basic Information
Table 91. Bristol-Myers Squibb Drugs based on Genetic Engineering Product Overview
Table 92. Bristol-Myers Squibb Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Recent Developments
Table 95. GlaxoSmithKline Basic Information
Table 96. GlaxoSmithKline Drugs based on Genetic Engineering Product Overview
Table 97. GlaxoSmithKline Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Recent Developments
Table 100. AbbVie Basic Information
Table 101. AbbVie Drugs based on Genetic Engineering Product Overview
Table 102. AbbVie Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. AbbVie Business Overview
Table 104. AbbVie Recent Developments
Table 105. Sandoz Basic Information
Table 106. Sandoz Drugs based on Genetic Engineering Product Overview
Table 107. Sandoz Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sandoz Business Overview
Table 109. Sandoz Recent Developments
Table 110. Biogen Basic Information
Table 111. Biogen Drugs based on Genetic Engineering Product Overview
Table 112. Biogen Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Biogen Business Overview
Table 114. Biogen Recent Developments
Table 115. Pfizer Basic Information
Table 116. Pfizer Drugs based on Genetic Engineering Product Overview
Table 117. Pfizer Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Pfizer Business Overview
Table 119. Pfizer Recent Developments
Table 120. GenSci Basic Information
Table 121. GenSci Drugs based on Genetic Engineering Product Overview
Table 122. GenSci Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. GenSci Business Overview
Table 124. GenSci Recent Developments
Table 125. 3SBIO Basic Information
Table 126. 3SBIO Drugs based on Genetic Engineering Product Overview
Table 127. 3SBIO Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. 3SBIO Business Overview
Table 129. 3SBIO Recent Developments
Table 130. Organon Pharma Basic Information
Table 131. Organon Pharma Drugs based on Genetic Engineering Product Overview
Table 132. Organon Pharma Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Organon Pharma Business Overview
Table 134. Organon Pharma Recent Developments
Table 135. Roche Basic Information
Table 136. Roche Drugs based on Genetic Engineering Product Overview
Table 137. Roche Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Roche Business Overview
Table 139. Roche Recent Developments
Table 140. Swedish Orphan Biovitrum Basic Information
Table 141. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Product Overview
Table 142. Swedish Orphan Biovitrum Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Swedish Orphan Biovitrum Business Overview
Table 144. Swedish Orphan Biovitrum Recent Developments
Table 145. CSPC Basic Information
Table 146. CSPC Drugs based on Genetic Engineering Product Overview
Table 147. CSPC Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. CSPC Business Overview
Table 149. CSPC Recent Developments
Table 150. Johnson and Johnson Basic Information
Table 151. Johnson and Johnson Drugs based on Genetic Engineering Product Overview
Table 152. Johnson and Johnson Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Johnson and Johnson Business Overview
Table 154. Johnson and Johnson Recent Developments
Table 155. Merck Basic Information
Table 156. Merck Drugs based on Genetic Engineering Product Overview
Table 157. Merck Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Merck Business Overview
Table 159. Merck Recent Developments
Table 160. Takeda Basic Information
Table 161. Takeda Drugs based on Genetic Engineering Product Overview
Table 162. Takeda Drugs based on Genetic Engineering Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Takeda Business Overview
Table 164. Takeda Recent Developments
Table 165. Global Drugs based on Genetic Engineering Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Drugs based on Genetic Engineering Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Drugs based on Genetic Engineering Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Drugs based on Genetic Engineering Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Drugs based on Genetic Engineering Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Drugs based on Genetic Engineering Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Drugs based on Genetic Engineering Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Drugs based on Genetic Engineering Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Drugs based on Genetic Engineering Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Drugs based on Genetic Engineering Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Drugs based on Genetic Engineering Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Drugs based on Genetic Engineering
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drugs based on Genetic Engineering Market Size (M USD), 2025-2035
Figure 5. Global Drugs based on Genetic Engineering Market Size (M USD) (2020-2035)
Figure 6. Global Drugs based on Genetic Engineering Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drugs based on Genetic Engineering Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drugs based on Genetic Engineering Product Life Cycle
Figure 13. Drugs based on Genetic Engineering Sales Share by Manufacturers in 2025
Figure 14. Global Drugs based on Genetic Engineering Revenue Share by Manufacturers in 2025
Figure 15. Drugs based on Genetic Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drugs based on Genetic Engineering Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drugs based on Genetic Engineering Revenue in 2025
Figure 18. Industry Chain Map of Drugs based on Genetic Engineering
Figure 19. Global Drugs based on Genetic Engineering Market PEST Analysis
Figure 20. Global Drugs based on Genetic Engineering Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drugs based on Genetic Engineering Market Share by Type
Figure 27. Sales Market Share of Drugs based on Genetic Engineering by Type (2020-2025)
Figure 28. Sales Market Share of Drugs based on Genetic Engineering by Type in 2025
Figure 29. Market Share of Drugs based on Genetic Engineering by Type (2020-2025)
Figure 30. Market Share of Drugs based on Genetic Engineering by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drugs based on Genetic Engineering Market Share by Application
Figure 33. Global Drugs based on Genetic Engineering Sales Market Share by Application (2020-2025)
Figure 34. Global Drugs based on Genetic Engineering Sales Market Share by Application in 2025
Figure 35. Global Drugs based on Genetic Engineering Market Share by Application (2020-2025)
Figure 36. Global Drugs based on Genetic Engineering Market Share by Application in 2025
Figure 37. Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drugs based on Genetic Engineering Sales Market Share by Region (2020-2025)
Figure 39. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025)
Figure 40. North America Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 43. North America Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 45. U.S. Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drugs based on Genetic Engineering Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Drugs based on Genetic Engineering Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drugs based on Genetic Engineering Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drugs based on Genetic Engineering Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 53. Europe Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 55. Germany Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Drugs based on Genetic Engineering Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drugs based on Genetic Engineering Market Size by Region in 2024
Figure 68. China Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 79. South America Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 80. South America Drugs based on Genetic Engineering Market Size and Growth Rate (M USD)
Figure 81. South America Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 82. Brazil Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Drugs based on Genetic Engineering Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drugs based on Genetic Engineering Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drugs based on Genetic Engineering Market Size by Region in 2024
Figure 92. Saudi Arabia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drugs based on Genetic Engineering Production Market Share by Region (2020-2025)
Figure 103. North America Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 106. China Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Drugs based on Genetic Engineering Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Drugs based on Genetic Engineering Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drugs based on Genetic Engineering Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drugs based on Genetic Engineering Market Share Forecast by Type (2026-2035)
Figure 111. Global Drugs based on Genetic Engineering Sales Forecast by Application (2026-2035)
Figure 112. Global Drugs based on Genetic Engineering Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Drugs based on Genetic Engineering
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Drugs based on Genetic Engineering Market Size (M USD), 2025-2035
Figure 5. Global Drugs based on Genetic Engineering Market Size (M USD) (2020-2035)
Figure 6. Global Drugs based on Genetic Engineering Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Drugs based on Genetic Engineering Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Drugs based on Genetic Engineering Product Life Cycle
Figure 13. Drugs based on Genetic Engineering Sales Share by Manufacturers in 2025
Figure 14. Global Drugs based on Genetic Engineering Revenue Share by Manufacturers in 2025
Figure 15. Drugs based on Genetic Engineering Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Drugs based on Genetic Engineering Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Drugs based on Genetic Engineering Revenue in 2025
Figure 18. Industry Chain Map of Drugs based on Genetic Engineering
Figure 19. Global Drugs based on Genetic Engineering Market PEST Analysis
Figure 20. Global Drugs based on Genetic Engineering Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Drugs based on Genetic Engineering Market Share by Type
Figure 27. Sales Market Share of Drugs based on Genetic Engineering by Type (2020-2025)
Figure 28. Sales Market Share of Drugs based on Genetic Engineering by Type in 2025
Figure 29. Market Share of Drugs based on Genetic Engineering by Type (2020-2025)
Figure 30. Market Share of Drugs based on Genetic Engineering by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Drugs based on Genetic Engineering Market Share by Application
Figure 33. Global Drugs based on Genetic Engineering Sales Market Share by Application (2020-2025)
Figure 34. Global Drugs based on Genetic Engineering Sales Market Share by Application in 2025
Figure 35. Global Drugs based on Genetic Engineering Market Share by Application (2020-2025)
Figure 36. Global Drugs based on Genetic Engineering Market Share by Application in 2025
Figure 37. Global Drugs based on Genetic Engineering Sales Growth Rate by Application (2020-2025)
Figure 38. Global Drugs based on Genetic Engineering Sales Market Share by Region (2020-2025)
Figure 39. Global Drugs based on Genetic Engineering Market Size by Region (2020-2025)
Figure 40. North America Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 43. North America Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 45. U.S. Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Drugs based on Genetic Engineering Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Drugs based on Genetic Engineering Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Drugs based on Genetic Engineering Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Drugs based on Genetic Engineering Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 53. Europe Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 55. Germany Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Drugs based on Genetic Engineering Sales Market Share by Region in 2024
Figure 67. Asia Pacific Drugs based on Genetic Engineering Market Size by Region in 2024
Figure 68. China Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 79. South America Drugs based on Genetic Engineering Sales Market Share by Country in 2024
Figure 80. South America Drugs based on Genetic Engineering Market Size and Growth Rate (M USD)
Figure 81. South America Drugs based on Genetic Engineering Market Size by Country in 2024
Figure 82. Brazil Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Drugs based on Genetic Engineering Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Drugs based on Genetic Engineering Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Drugs based on Genetic Engineering Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Drugs based on Genetic Engineering Market Size by Region in 2024
Figure 92. Saudi Arabia Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Drugs based on Genetic Engineering Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Drugs based on Genetic Engineering Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Drugs based on Genetic Engineering Production Market Share by Region (2020-2025)
Figure 103. North America Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 106. China Drugs based on Genetic Engineering Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Drugs based on Genetic Engineering Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Drugs based on Genetic Engineering Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Drugs based on Genetic Engineering Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Drugs based on Genetic Engineering Market Share Forecast by Type (2026-2035)
Figure 111. Global Drugs based on Genetic Engineering Sales Forecast by Application (2026-2035)
Figure 112. Global Drugs based on Genetic Engineering Market Share Forecast by Application (2026-2035)
